Published in Cardiovasc Res on May 01, 2002
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest (2013) 1.49
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
Cardiac strong inward rectifier potassium channels. J Mol Cell Cardiol (2009) 1.19
Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria. J Physiol (2013) 1.18
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets. FASEB J (2010) 1.07
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc Res (2010) 1.05
Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm (2009) 1.00
Electrophysiological evidence for a gradient of G protein-gated K+ current in adult mouse atria. Br J Pharmacol (2003) 0.94
Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol (2007) 0.92
Gender differences in electrophysiological gene expression in failing and non-failing human hearts. PLoS One (2013) 0.89
Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.87
SAP97 regulates Kir2.3 channels by multiple mechanisms. Am J Physiol Heart Circ Physiol (2009) 0.86
An emerging role for the miR-26 family in cardiovascular disease. Trends Cardiovasc Med (2014) 0.84
G-protein-coupled inward rectifier potassium current contributes to ventricular repolarization. Cardiovasc Res (2013) 0.81
Cardiac IK1 underlies early action potential shortening during hypoxia in the mouse heart. J Mol Cell Cardiol (2007) 0.80
TASK-1 current is inhibited by phosphorylation during human and canine chronic atrial fibrillation. Am J Physiol Heart Circ Physiol (2014) 0.78
[Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]. Z Kardiol (2004) 0.78
Mechanisms of postcardiac surgery atrial fibrillation: more pieces in a difficult puzzle. Heart Rhythm (2009) 0.77
Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria. PLoS Comput Biol (2017) 0.77
The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in dedicated goat and dog models. Br J Pharmacol (2017) 0.76
Looking into a conceptual framework of ROS-miRNA-atrial fibrillation. Int J Mol Sci (2014) 0.76
A Computer Simulation Study of Anatomy Induced Drift of Spiral Waves in the Human Atrium. Biomed Res Int (2015) 0.76
Inward rectifier potassium (Kir) current in dopaminergic periglomerular neurons of the mouse olfactory bulb. Front Cell Neurosci (2014) 0.76
Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation. Cardiol Rev (2016) 0.76
Constitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation. Sci Rep (2015) 0.76
Voltage-dependent open-channel block of G protein-gated inward-rectifying K(+) (GIRK) current in rat atrial myocytes by tamoxifen. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75
Chronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study. Biomed Res Int (2015) 0.75
A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J Mol Cell Cardiol (2012) 2.71
Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation (2012) 2.58
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace (2009) 2.52
Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol (2008) 2.37
Early detection of mechanical valve dysfunction using a new home monitoring device. Ann Thorac Surg (2007) 2.18
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
Is the mediastinal lymphadenectomy during pulmonary metastasectomy of colorectal cancer necessary? Interact Cardiovasc Thorac Surg (2010) 2.08
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation. Circulation (2006) 2.00
Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J (2007) 1.90
Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation (2004) 1.77
Surgery for atrial fibrillation in patients with mitral valve disease: results at five years from the International Registry of Atrial Fibrillation Surgery. J Thorac Cardiovasc Surg (2008) 1.76
Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. Cardiovasc Res (2006) 1.62
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res (2009) 1.58
Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Electrophysiological properties of human mesenchymal stem cells. J Physiol (2003) 1.53
Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.49
Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol (2005) 1.43
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol (2005) 1.37
Adult zebrafish heart as a model for human heart? An electrophysiological study. J Mol Cell Cardiol (2009) 1.29
KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation (2004) 1.29
Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J (2003) 1.21
Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol (2004) 1.21
Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications. Cardiovasc Res (2010) 1.21
Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol (2003) 1.20
Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Arch (2009) 1.20
Ionic mechanisms limiting cardiac repolarization reserve in humans compared to dogs. J Physiol (2013) 1.17
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J Mol Cell Cardiol (2008) 1.09
Entrapped coronary catheter remnants and stents: must they be surgically removed? Tex Heart Inst J (2006) 1.09
Specific beta(2)AR blocker ICI 118,551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation (2002) 1.07
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res (2007) 1.06
Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol (2003) 1.06
Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. J Thorac Cardiovasc Surg (2005) 1.05
Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ Arrhythm Electrophysiol (2010) 1.05
Inotropy and L-type Ca2+ current, activated by beta1- and beta2-adrenoceptors, are differently controlled by phosphodiesterases 3 and 4 in rat heart. Br J Pharmacol (2009) 1.02
Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res (2007) 1.01
Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea]. Mol Pharmacol (2006) 1.01
Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Eur Heart J (2009) 1.00
Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res (2005) 0.98
Contribution of Ca2+ influx to carbachol-induced detrusor contraction is different in human urinary bladder compared to pig and mouse. Eur J Pharmacol (2007) 0.96
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J (2009) 0.96
Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors. Stem Cells (2012) 0.96
Adult human heart slices are a multicellular system suitable for electrophysiological and pharmacological studies. J Mol Cell Cardiol (2011) 0.96
Tissue slices from adult mammalian hearts as a model for pharmacological drug testing. Cell Physiol Biochem (2009) 0.95
Tissue distribution of a human Ca v 1.2 alpha1 subunit splice variant with a 75 bp insertion. Cell Calcium (2005) 0.94
Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther (2008) 0.94
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol (2005) 0.94
Human electrophysiological and pharmacological properties of XEN-D0101: a novel atrial-selective Kv1.5/IKur inhibitor. J Cardiovasc Pharmacol (2013) 0.93
The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res (2013) 0.93
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. J Clin Invest (2014) 0.93
Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia. Transpl Int (2005) 0.93
Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future Cardiol (2009) 0.93
Heart-focused anxiety before and after cardiac surgery. J Psychosom Res (2008) 0.92
The impact of rapid atrial pacing on ADMA and endothelial NOS. Int J Cardiol (2010) 0.92
Atrial selectivity of antiarrhythmic drugs. J Physiol (2013) 0.89
5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res (2006) 0.89
Complex pleural empyema can be safely treated with vacuum-assisted closure. J Cardiothorac Surg (2011) 0.89
Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol (2005) 0.88
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.88
Design and validation of a bioreactor for simulating the cardiac niche: a system incorporating cyclic stretch, electrical stimulation, and constant perfusion. Tissue Eng Part A (2012) 0.88
A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Toxicon (2006) 0.88
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. Eur J Pharmacol (2011) 0.88
Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J (2003) 0.88
Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res (2009) 0.87
Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.87
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. Cardiovasc Res (2005) 0.87
PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. Br J Pharmacol (2013) 0.87
Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol (2011) 0.86
Beta adrenergic receptor-mediated atrial specific up-regulation of RGS5. Life Sci (2004) 0.86
Differentiation of chromaffin progenitor cells to dopaminergic neurons. Cell Transplant (2012) 0.86
Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes. J Mol Cell Cardiol (2006) 0.85
Cardiac tissue engineering. Transpl Immunol (2002) 0.85
Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart. Br J Pharmacol (2002) 0.85
Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin. Int J Cardiol (2009) 0.85
Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.85